(Q39113728)

9 September 2017

title

MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells (English)

1 reference

9 September 2017

main subject

multiple drug resistance

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

Tao Yang

1

1 reference

9 September 2017

Zhi-Min Zheng

2

1 reference

9 September 2017

Xiao-Na Li

3

1 reference

9 September 2017

Zhen-Fu Li

4

1 reference

9 September 2017

Yan Wang

5

1 reference

9 September 2017

Yun-Feng Geng

6

1 reference

9 September 2017

Li Bai

7

1 reference

9 September 2017

Xian-Bo Zhang

8

1 reference

9 September 2017

publication date

7 August 2013

1 reference

Experimental Biology and Medicine

9 September 2017

published in

1 reference

9 September 2017

volume

238

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

1024-1032

1 reference

9 September 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

The Role of ABC Transporters in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1535370213497321

21 January 2018

Identifiers

DOI

10.1177/1535370213497321

1 reference

9 September 2017

1 reference